These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 6623024)
1. [Pheochromocytoma and sympathetic paragangliomas]. Zollinger R; Hedinger C Schweiz Med Wochenschr; 1983 Jul; 113(30):1057-65. PubMed ID: 6623024 [TBL] [Abstract][Full Text] [Related]
2. [Pheochromocytoma and sympathetic paraganglioma. 2. Combination with typical associated diseases. Familial occurrence]. Zollinger R; Hedinger C Schweiz Med Wochenschr; 1983 Aug; 113(31-32):1086-92. PubMed ID: 6137873 [TBL] [Abstract][Full Text] [Related]
3. [Pheochromocytoma--pathohistologic and immunohistochemical aspects]. Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991 [TBL] [Abstract][Full Text] [Related]
4. Nonsporadic cases and unusual morphological features in pheochromocytoma and paraganglioma. Lamovec J; Frković-Grazio S; Bracko M Arch Pathol Lab Med; 1998 Jan; 122(1):63-8. PubMed ID: 9448019 [TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute. Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251 [TBL] [Abstract][Full Text] [Related]
6. [Incidence of medullary thyroid gland carcinoma in unilateral and bilateral pheochromocytoma]. Pusterla E; Hedinger C Schweiz Med Wochenschr; 1975 Jan; 105(3):83-7. PubMed ID: 1121658 [TBL] [Abstract][Full Text] [Related]
7. [Can pheochromocytoma be considered a benign unilateral intra-adrenal sporadic hypertensive tumor ? Reflections on a series of 105 surgically treated subdiaphragmatic chromaffin tumors]. Proye C; Vix M; Goropoulos A; Carnaille B; Vermesse B; Kerlo P; Lecomte-Houcke M Chirurgie; 1992; 118(8):433-8. PubMed ID: 1343986 [TBL] [Abstract][Full Text] [Related]
8. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. Ayala-Ramirez M; Feng L; Johnson MM; Ejaz S; Habra MA; Rich T; Busaidy N; Cote GJ; Perrier N; Phan A; Patel S; Waguespack S; Jimenez C J Clin Endocrinol Metab; 2011 Mar; 96(3):717-25. PubMed ID: 21190975 [TBL] [Abstract][Full Text] [Related]
9. Pathology of pheochromocytoma and extra-adrenal paraganglioma. Tischler AS; Kimura N; Mcnicol AM Ann N Y Acad Sci; 2006 Aug; 1073():557-70. PubMed ID: 17102124 [TBL] [Abstract][Full Text] [Related]
10. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma. Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105 [TBL] [Abstract][Full Text] [Related]
11. Intra-tumoral molecular heterogeneity in benign and malignant pheochromocytomas and extra-adrenal sympathetic paragangliomas. Korpershoek E; Stobbe CK; van Nederveen FH; de Krijger RR; Dinjens WN Endocr Relat Cancer; 2010 Sep; 17(3):653-62. PubMed ID: 20488782 [TBL] [Abstract][Full Text] [Related]
12. [Malignant pheochromocytoma. A case report and comments on a rare pathology]. Boneschi M; Erba M; Rinaldi P; Cusmai F; Miani S Minerva Chir; 1999; 54(1-2):73-8. PubMed ID: 10230231 [TBL] [Abstract][Full Text] [Related]
13. Changes in urinary total metanephrine excretion in recurrent and malignant pheochromocytomas and secreting paragangliomas. Amar L; Peyrard S; Rossignol P; Zinzindohoue F; Gimenez-Roqueplo AP; Plouin PF Ann N Y Acad Sci; 2006 Aug; 1073():383-91. PubMed ID: 17102107 [TBL] [Abstract][Full Text] [Related]
14. [Biological study the paragangliomas in a case of Sipple's syndrome]. Masse-Labadie G; Duc M C R Seances Soc Biol Fil; 1967; 161(6):1407-11. PubMed ID: 4232823 [No Abstract] [Full Text] [Related]